Karpus Investment Management’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Karpus Investment Management’s Portfolio ISLE Stock Details ISLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-696,631	Closed	-$6.94M	–	552
2022 Q2	$6.94M	Sell	696,631 -30,625	-4%	-$304K	0.23%	97
2022 Q1	$7.2M	Sell	727,256 -9,448	-1%	-$93.1K	0.22%	104
2021 Q4	$7.25M	Sell	736,704 -13,285	-2%	-$131K	0.21%	111
2021 Q3	$7.37M	Sell	749,989 -21,000	-3%	-$205K	0.22%	104
2021 Q2	$7.56M	Sell	770,989 -28,536	-4%	-$279K	0.22%	107
2021 Q1	$7.75M	Buy	+799,525	New	+$7.73M	0.23%	104

Karpus Investment Management's ISLE Position: Q3 2022 in Review

Karpus Investment Management sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 696,631 shares — an estimated $6.94M sold.

Karpus Investment Management first reported a position in ISLE in Q1 2021 and held it in 6 quarters. The position peaked at $7.75M in Q1 2021. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

Karpus Investment Management reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
Karpus Investment Management sold 696,631 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $6.94M.
Karpus Investment Management first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 6 quarters.
Karpus Investment Management's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $7.75M in Q1 2021.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Karpus Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.